Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Candesartan vs Hydrochlorothiazide on Insulin Sensitivity in Hypertensive Obese Patients
NCT00282178Phase 2Completed
- Sponsor
- Umeå University
- Start
- Apr 2005
- Primary completion
- Mar 2006
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of candesartan in hypertension (HTN), sponsored by Umeå University. Started Apr 2005; status: completed.
02
Drugs
candesartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00282178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00282178.